SEM

Select Medical Holdings Corporation (SEM) SWOT Analysis Analysis (2026)

Invetso Score: 4.2/10 — Balanced · Last Updated: 2026-08-01

Strengths

SEM’s ROIC of 4.8% indicates modest capital efficiency, but it still compares favorably with weaker peers that destroy more value through persistent under-earning.

A current ratio of 1.15 shows near-term liquidity coverage, which is adequate versus more stretched peers even though it leaves limited balance-sheet flexibility.

The company’s cash conversion cycle of 50.5 days is manageable for a manufacturing business, supporting working-capital discipline relative to slower-turning peers.

Weaknesses

Net debt to EBITDA of 5.7x is elevated, leaving SEM more levered than many peers and constraining strategic flexibility through higher fixed financial obligations.

Debt to equity of 1.7x signals a meaningfully leveraged capital structure, which is structurally weaker than less indebted competitors in cyclical end markets.

ROIC of 4.8% remains below a strong cost-of-capital hurdle, implying SEM is less effective than higher-return peers at compounding invested capital.

A cash conversion cycle above 50 days ties up working capital longer than best-in-class peers, reducing liquidity efficiency and internal funding capacity.

Opportunities

If SEM improves working-capital turns, the 50.5-day cash conversion cycle leaves room to release cash faster than peers with similarly long operating cycles.

A moderate liquidity position can support incremental operational improvement, allowing SEM to narrow the gap with peers that already convert earnings into cash more efficiently.

Any sustained uplift in capital efficiency would matter disproportionately because SEM’s current ROIC is only modest, leaving room to close the peer-return gap.

Threats

High leverage increases sensitivity to earnings volatility, making SEM more vulnerable than lower-debt peers if demand weakens or refinancing costs rise.

A long cash conversion cycle raises working-capital strain during downturns, which can pressure SEM more than peers with faster inventory and receivables turns.

Because ROIC is already modest, competitive pricing pressure or cost inflation could leave SEM lagging peers that have more resilient return profiles.

Overall Score

SEM’s structural positioning is mixed, with acceptable liquidity and working-capital discipline offset by elevated leverage and only modest capital returns versus peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Select Medical Holdings Corporation. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →